X-15244547-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001031739.3(ASB9):c.844G>A(p.Val282Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,194,145 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001031739.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASB9 | NM_001031739.3 | c.844G>A | p.Val282Ile | missense_variant | 7/7 | ENST00000380488.9 | NP_001026909.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000361 AC: 4AN: 110858Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33118
GnomAD3 exomes AF: 0.0000274 AC: 5AN: 182778Hom.: 0 AF XY: 0.0000595 AC XY: 4AN XY: 67244
GnomAD4 exome AF: 0.00000831 AC: 9AN: 1083287Hom.: 0 Cov.: 29 AF XY: 0.0000142 AC XY: 5AN XY: 352967
GnomAD4 genome AF: 0.0000361 AC: 4AN: 110858Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33118
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | The c.844G>A (p.V282I) alteration is located in exon 7 (coding exon 7) of the ASB9 gene. This alteration results from a G to A substitution at nucleotide position 844, causing the valine (V) at amino acid position 282 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at